Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Healthcare Finance: Solicitor general weighs in on Supreme Court review of drug price negotiations
On Jan. 1, the first round of negotiated drug prices took effect. Among the drugs targeted in the first round was Farxiga, a drug made by AstraZeneca. CMS selected the 10 drugs in August 2023. The drugs accounted for $50 billion of gross Medicare Part D prescription drug costs between June 2022 and May 2023. […]
News and Reports
Axios: Drug prices to keep rising through Trump's term
Advocacy group Patients for Affordable Drugs said in response to the survey results that the IRA’s reforms are working for seniors. “[T]hat’s exactly why expanding and protecting the law matters,” Alyson Bancroft, director of policy, legislation and alliances, told Axios in an email. Health and Human Services communications director Andrew Nixon told Axios the agency […]
News and Reports
Epoch Times: Lower Prices for 10 Medicare Drugs Now in Effect: What to Know
Merith Basey, CEO for Patients For Affordable Drugs, said the negotiation brought overdue accountability to pharmaceutical manufacturers who have long charged higher prices to U.S. customers than to those in other countries. “This is a historic step, but it cannot be the last,” Basey said in a Jan. 1 statement. “Medicare negotiation must be protected, […]
News and Reports
Bloomberg Law: Trump, Biden Drug Price Control Efforts Set to Collide in 2026
Still, advocacy groups like Patients for Affordable Drugs have been supporting the program, viewing it as the “heart of what is really lowering drug prices,” according to its CEO, Merith Basey.
News and Reports
Bloomberg: Cancer’s Soaring Cost Wrecks Patients’ Finances in a Broken System
As part of the Inflation Reduction Act in 2022, Congress capped patient out-of-pocket costs at $2,000 in the Medicare prescription drug program. Trapp, who’s now a patient advocate for a non-profit group called Patients for Affordable Drugs, said that helped limit her own expenses once she qualified for Medicare through disability. But the cap only applies […]
Press Releases
Medicare’s First Negotiated Drug Prices Take Effect: a Win for Patients
Patients on Medicare begin seeing an average list price reduction of 63% percent on the first 10 blockbuster drugs starting January 1st WASHINGTON, D.C. — Today marks a historic milestone for prescription drug affordability in the United States. For the first time in Medicare’s history, lower negotiated prices for 10 of the most expensive and widely used prescription […]
News and Reports
IP Watchdog: Current and Former Lawmakers Lock Horns in Comments on USPTO’s Proposed PTAB Changes
Patients For Affordable Drugs (P4AD)“strongly oppose[s]” the proposed rule because, according to their submission, the PTAB “allows for more efficient, accessible, and affordable challenges to invalid patents,” particularly in the context of pharmaceutical patents. Prior to the American Invents Act (AIA), said P4AD, invalidating pharma patents “cost millions of dollars in district courts, harmed many communities, […]
News and Reports
Inside Health Policy: CMS Will Drop Three Part D Drugs From IRA Pricing Program In 2027
The upcoming removal of Entresto, Stelara and Xarelto from the negotiation program appears to be consistent with the inflation Reduction Act’s procedure for dropping drugs once competition enters the market. “The Medicare Negotiation Program was designed to serve as a check on the monopoly power of the pharmaceutical industry and the highest-cost and most commonly […]